Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Transdermal Patch Market Research Report 2015-2025

  • HEY3759169
  • 88 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The global Transdermal Patch market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Fentanyl Transdermal Patch

Nicotine Transdermal Patch

Buprenorphine Transdermal Patch

Clonidine Transdermal Patch

Oxybutynin Transdermal Patch

Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Transdermal Patch Picture

1.1.2 Specifications

Table Product Specifications of Transdermal Patch

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Transdermal Patch

Table Global Transdermal Patch Market by Type, 2011-2022 (USD Million)

1.2.1.1 Fentanyl Transdermal Patch

Table Fentanyl Transdermal Patch Overview

1.2.1.2 Nicotine Transdermal Patch

Table Nicotine Transdermal Patch Overview

1.2.1.3 Buprenorphine Transdermal Patch

Table Buprenorphine Transdermal Patch Overview

1.2.1.4 Clonidine Transdermal Patch

Table Clonidine Transdermal Patch Overview

1.2.1.5 Oxybutynin Transdermal Patch

Table Oxybutynin Transdermal Patch Overview

1.2.1.6 Others

Table Others Overview

1.2.2 by Application

Table Application Segment of Transdermal Patch

Table Global Transdermal Patch Market by Application, 2011-2022 (USD Million)

1.2.2.1 The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Overview

1.2.2.2 Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Overview

1.2.2.3 Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Overview

1.2.2.4 Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Overview

1.2.2.5 Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Overview

1.2.2.6 Others

Table Others Overview

1.2.3 by Regions

Table Global Transdermal Patch Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Transdermal Patch

2.2 Upstream

Table Cost of Transdermal Patch

Figure Manufacturing Process of Transdermal Patch

2.3 Market

2.3.1 SWOT

Figure SWOT of Transdermal Patch

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Transdermal Patch

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Transdermal Patch

3.4 Market Entry

Table Market Entry of Transdermal Patch

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Fentanyl Transdermal Patch Market, 2013-2018

Figure Fentanyl Transdermal Patch Market Size and Growth, 2015-2019 (USD Million)

Figure Fentanyl Transdermal Patch Market Size and Growth, 2015-2019 (in Volume)

Table Fentanyl Transdermal Patch CAGR by Revenue and Volume, 2015-2019

4.1.2 Nicotine Transdermal Patch Market, 2013-2018

Figure Nicotine Transdermal Patch Market Size and Growth, 2015-2019 (USD Million)

Figure Nicotine Transdermal Patch Market Size and Growth, 2015-2019 (in Volume)

Table Nicotine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

4.1.3 Buprenorphine Transdermal Patch Market, 2013-2018

Figure Buprenorphine Transdermal Patch Market Size and Growth, 2015-2019 (USD Million)

Figure Buprenorphine Transdermal Patch Market Size and Growth, 2015-2019 (in Volume)

Table Buprenorphine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

4.1.4 Clonidine Transdermal Patch Market, 2013-2018

Figure Clonidine Transdermal Patch Market Size and Growth, 2015-2019 (USD Million)

Figure Clonidine Transdermal Patch Market Size and Growth, 2015-2019 (in Volume)

Table Clonidine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

4.1.5 Oxybutynin Transdermal Patch Market, 2013-2018

Figure Oxybutynin Transdermal Patch Market Size and Growth, 2015-2019 (USD Million)

Figure Oxybutynin Transdermal Patch Market Size and Growth, 2015-2019 (in Volume)

Table Oxybutynin Transdermal Patch CAGR by Revenue and Volume, 2015-2019

4.1.6 Others Market, 2013-2018

Figure Others Market Size and Growth, 2015-2019 (USD Million)

Figure Others Market Size and Growth, 2015-2019 (in Volume)

Table Others CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 Fentanyl Transdermal Patch Market Forecast, 2020-2025

Figure Fentanyl Transdermal Patch Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Fentanyl Transdermal Patch Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Fentanyl Transdermal Patch CAGR by Revenue and Volume, 2012-2024

4.2.2 Nicotine Transdermal Patch Market Forecast, 2020-2025

Figure Nicotine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Nicotine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Nicotine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

4.2.3 Buprenorphine Transdermal Patch Market Forecast, 2020-2025

Figure Buprenorphine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Buprenorphine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Buprenorphine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

4.2.4 Clonidine Transdermal Patch Market Forecast, 2020-2025

Figure Clonidine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Clonidine Transdermal Patch Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Clonidine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

4.2.5 Oxybutynin Transdermal Patch Market Forecast, 2020-2025

Figure Oxybutynin Transdermal Patch Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Oxybutynin Transdermal Patch Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Oxybutynin Transdermal Patch CAGR by Revenue and Volume, 2012-2024

4.2.6 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market, 2013-2018

Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. CAGR by Revenue and Volume, 2015-2019

5.1.2 Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market, 2013-2018

Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. CAGR by Revenue and Volume, 2015-2019

5.1.3 Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market, 2013-2018

Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. CAGR by Revenue and Volume, 2015-2019

5.1.4 Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market, 2013-2018

Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. CAGR by Revenue and Volume, 2015-2019

5.1.5 Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market, 2013-2018

Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. CAGR by Revenue and Volume, 2015-2019

5.1.6 Others Market, 2013-2018

Figure Others Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Others CAGR by Revenue and Volume, 2015-2019

5.2 Market Forecast

5.2.1 The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Forecast, 2020-2025

Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Estimates and Forecasts, 2020-2025 (in Volume)

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. CAGR by Revenue and Volume, 2020-2025

5.2.2 Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Forecast, 2020-2025

Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. CAGR by Revenue and Volume, 2020-2025

5.2.3 Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Forecast, 2020-2025

Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. CAGR by Revenue and Volume, 2020-2025

5.2.4 Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Forecast, 2020-2025

Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. CAGR by Revenue and Volume, 2020-2025

5.2.5 Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Forecast, 2020-2025

Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. CAGR by Revenue and Volume, 2020-2025

5.2.6 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2015-2019

Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)

Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

6.1.2 North America

6.1.2.1 North America Market, 2015-2019

Figure North America Market Size and Growth, 2015-2019 (USD Million)

Figure North America Market Size and Growth, 2015-2019 (in Volume)

Table North America CAGR by Revenue and Volume, 2015-2019

6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2015-2019

Figure Europe Market Size and Growth, 2015-2019 (USD Million)

Figure Europe Market Size and Growth, 2015-2019 (in Volume)

Table Europe CAGR by Revenue and Volume, 2015-2019

6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

6.1.4 South America

6.1.4.1 South America Market, 2015-2019

Figure South America Market Size and Growth, 2015-2019 (USD Million)

Figure South America Market Size and Growth, 2015-2019 (in Volume)

Table South America CAGR by Revenue and Volume, 2015-2019

6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2015-2019

Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

7.1 Global Market by Vendors

Table Global Transdermal Patch Market by Vendors, 2015-2019 (in Volume)

Table Global Transdermal Patch Market Share by Vendors, 2015-2019 (USD Million)

Table Global Transdermal Patch Market Share by Vendors, 2015-2019 (in Volume)

7.2 Market Concentration

Figure Transdermal Patch Market Concentration by Region

7.3 Price & Factors

Table Price Factors List

7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

8.1 Hisamitsu Pharmaceutical

Table Hisamitsu Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Hisamitsu Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.2 Novartis

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.3 Johnson & Johnson

Table Johnson & Johnson Profile List

Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.4 Teikoku Pharma

Table Teikoku Pharma Profile List

Table Microecological Modulator Operating Data of Teikoku Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.5 Mylan

Table Mylan Profile List

Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.6 Actavis

Table Actavis Profile List

Table Microecological Modulator Operating Data of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.7 Mundipharma

Table Mundipharma Profile List

Table Microecological Modulator Operating Data of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.8 Henan Lingrui Pharmaceutical

Table Henan Lingrui Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Henan Lingrui Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.9 Changzhou Siyao

Table Changzhou Siyao Profile List

Table Microecological Modulator Operating Data of Changzhou Siyao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.10 Rfl Pharmaceutical

Table Rfl Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Rfl Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

List of Table

Table Product Specifications of Transdermal Patch

Table Products Segment of Transdermal Patch

Table Global Transdermal Patch Market by Type, 2011-2022 (USD Million)

Table Fentanyl Transdermal Patch Overview

Table Nicotine Transdermal Patch Overview

Table Buprenorphine Transdermal Patch Overview

Table Clonidine Transdermal Patch Overview

Table Oxybutynin Transdermal Patch Overview

Table Others Overview

Table Application Segment of Transdermal Patch

Table Global Transdermal Patch Market by Application, 2011-2022 (USD Million)

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Overview

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Overview

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Overview

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Overview

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Overview

Table Others Overview

Table Global Transdermal Patch Market by Region, 2011-2022 (USD Million)

Table Cost of Transdermal Patch

Table Market Dynamics

Table Policy of Transdermal Patch

Table GDP of Major Countries

Table Technology of Transdermal Patch

Table Market Entry of Transdermal Patch

Table Fentanyl Transdermal Patch CAGR by Revenue and Volume, 2015-2019

Table Nicotine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

Table Buprenorphine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

Table Clonidine Transdermal Patch CAGR by Revenue and Volume, 2015-2019

Table Oxybutynin Transdermal Patch CAGR by Revenue and Volume, 2015-2019

Table Others CAGR by Revenue and Volume, 2015-2019

Table Fentanyl Transdermal Patch CAGR by Revenue and Volume, 2012-2024

Table Nicotine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

Table Buprenorphine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

Table Clonidine Transdermal Patch CAGR by Revenue and Volume, 2012-2024

Table Oxybutynin Transdermal Patch CAGR by Revenue and Volume, 2012-2024

Table Others CAGR by Revenue and Volume, 2012-2024

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. CAGR by Revenue and Volume, 2015-2019

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. CAGR by Revenue and Volume, 2015-2019

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. CAGR by Revenue and Volume, 2015-2019

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. CAGR by Revenue and Volume, 2015-2019

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. CAGR by Revenue and Volume, 2015-2019

Table Others CAGR by Revenue and Volume, 2015-2019

Table The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. CAGR by Revenue and Volume, 2020-2025

Table Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. CAGR by Revenue and Volume, 2020-2025

Table Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. CAGR by Revenue and Volume, 2020-2025

Table Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. CAGR by Revenue and Volume, 2020-2025

Table Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. CAGR by Revenue and Volume, 2020-2025

Table Others CAGR by Revenue and Volume, 2020-2025

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

Table North America CAGR by Revenue and Volume, 2015-2019

Table Europe CAGR by Revenue and Volume, 2015-2019

Table South America CAGR by Revenue and Volume, 2015-2019

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

Table North America CAGR by Revenue and Volume, 2020-2025

Table Europe CAGR by Revenue and Volume, 2020-2025

Table South America CAGR by Revenue and Volume, 2020-2025

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

Table Global Transdermal Patch Market by Vendors, 2015-2019 (in Volume)

Table Global Transdermal Patch Market Share by Vendors, 2015-2019 (USD Million)

Table Global Transdermal Patch Market Share by Vendors, 2015-2019 (in Volume)

Table Price Factors List

Table Hisamitsu Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Hisamitsu Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Profile List

Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teikoku Pharma Profile List

Table Microecological Modulator Operating Data of Teikoku Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Profile List

Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actavis Profile List

Table Microecological Modulator Operating Data of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mundipharma Profile List

Table Microecological Modulator Operating Data of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Henan Lingrui Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Henan Lingrui Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Changzhou Siyao Profile List

Table Microecological Modulator Operating Data of Changzhou Siyao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Rfl Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Rfl Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950